NextPharma inaugurates new production facility for liquid pharmaceuticals in Limay, France

"This project reflects our commitment to bringing the production of essential medicines back to France..."

09-Sep-2025

NextPharma announces the inauguration ceremony of its new liquid pharmaceutical production plant at the Limay site (Yvelines, 78) on September 12, 2025. The new plant is the result of the NextFly project, which is part of the French government's strategic plan for the reshoring of essential medicines production, presented on January 6, 2025. Supported by the France 2030 initiative, this investment strengthens NextPharma's role in promoting national health sovereignty and industrial innovation.

NextPharma GmbH

The new facility at NextPharma's center of excellence in Limay specializes in the production of non-sterile liquid pharmaceuticals, including levetiracetam, an important drug for the treatment of epilepsy. The expansion doubled the site's production capacity and supports NextPharma's corporate strategy of increasing competitiveness while maintaining the highest international quality standards.

"The inauguration of our new production facility marks a milestone for NextPharma Limay," explains Bertrand PIHA, Site Manager. "This project reflects our commitment to bring the production of essential medicines back to France and to strengthen national health sovereignty. We have actively involved local and national partners to promote skills development and employment. We are thus making a proud contribution to the economic regeneration of the Grand Paris Seine & Oise region."

Partners, customers and institutional representatives are expected to attend the inauguration. The program includes a guided tour of the new facility, official speeches and a cocktail lunch afterwards.

Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of current news. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.

Other news from the department manufacturing

Most read news

More news from our other portals

Last viewed contents

Spanish startup receives investment for novel disinfection method against “killer fungus” - The UJI spin-off Molecular Sustainable Solutions receives an investment from BeAble Capital to boost its disinfection and sterilization methods

Spanish startup receives investment for novel disinfection method against “killer fungus” - The UJI spin-off Molecular Sustainable Solutions receives an investment from BeAble Capital to boost its disinfection and sterilization methods

Merck Opens Climate-Neutral €150 Million Manufacturing Facility in Ireland - The Blarney Business Park facility is part of Merck’s largest Life Science investment to date

Merck Opens Climate-Neutral €150 Million Manufacturing Facility in Ireland - The Blarney Business Park facility is part of Merck’s largest Life Science investment to date

Simtra BioPharma Solutions expands U.S. manufacturing capacity for injectable medicines - Simtra positioned to become the first CDMO to offer commercial-scale drug product manufacturing of antibody-drug conjugates in the United States

Simtra BioPharma Solutions expands U.S. manufacturing capacity for injectable medicines - Simtra positioned to become the first CDMO to offer commercial-scale drug product manufacturing of antibody-drug conjugates in the United States

CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE

CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE

ChatGPT grows insect-toxic genetically engineered plant - Blind spot in the EU draft law on genetic engineering

ChatGPT grows insect-toxic genetically engineered plant - Blind spot in the EU draft law on genetic engineering

Commission launches new strategy to make Europe a global leader in life sciences by 2030

Commission launches new strategy to make Europe a global leader in life sciences by 2030

CureVac Announces Resolution of Patent Litigation with Pfizer/BioNTech - BioNTech’s acquisition of CureVac will be implemented as planned

CureVac Announces Resolution of Patent Litigation with Pfizer/BioNTech - BioNTech’s acquisition of CureVac will be implemented as planned

Ibidi Awarded With the German bAV Prize 2023

Ibidi Awarded With the German bAV Prize 2023

Using AI as an exam tutor - Artificial intelligence is set to help human examinees study more effectively

Using AI as an exam tutor - Artificial intelligence is set to help human examinees study more effectively

EXIST start-up grant for virtual reality laboratory training - "Wet-Lab-VR": Virtual reality technology revolutionises training for molecular biology laboratories

EXIST start-up grant for virtual reality laboratory training - "Wet-Lab-VR": Virtual reality technology revolutionises training for molecular biology laboratories

Sustainable Plastics from Plants - Innovative interdisciplinary education model

Sustainable Plastics from Plants - Innovative interdisciplinary education model

How immune cells become accomplices of tumors - Langener Wissenschaftspreis awarded to DKFZ researcher Daniel Kirschenbaum

How immune cells become accomplices of tumors - Langener Wissenschaftspreis awarded to DKFZ researcher Daniel Kirschenbaum